1. Home
  2. NKTR vs THTX Comparison

NKTR vs THTX Comparison

Compare NKTR & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • THTX
  • Stock Information
  • Founded
  • NKTR 1990
  • THTX 1993
  • Country
  • NKTR United States
  • THTX Canada
  • Employees
  • NKTR N/A
  • THTX N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • THTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NKTR Health Care
  • THTX Health Care
  • Exchange
  • NKTR Nasdaq
  • THTX Nasdaq
  • Market Cap
  • NKTR 108.3M
  • THTX 119.1M
  • IPO Year
  • NKTR 1994
  • THTX N/A
  • Fundamental
  • Price
  • NKTR $24.73
  • THTX $3.14
  • Analyst Decision
  • NKTR Strong Buy
  • THTX Hold
  • Analyst Count
  • NKTR 6
  • THTX 1
  • Target Price
  • NKTR $81.67
  • THTX N/A
  • AVG Volume (30 Days)
  • NKTR 4.9M
  • THTX 1.1M
  • Earning Date
  • NKTR 08-07-2025
  • THTX 07-09-2025
  • Dividend Yield
  • NKTR N/A
  • THTX N/A
  • EPS Growth
  • NKTR N/A
  • THTX N/A
  • EPS
  • NKTR N/A
  • THTX N/A
  • Revenue
  • NKTR $87,248,000.00
  • THTX $84,378,000.00
  • Revenue This Year
  • NKTR N/A
  • THTX N/A
  • Revenue Next Year
  • NKTR N/A
  • THTX $15.13
  • P/E Ratio
  • NKTR N/A
  • THTX N/A
  • Revenue Growth
  • NKTR N/A
  • THTX 2.19
  • 52 Week Low
  • NKTR $6.48
  • THTX $1.12
  • 52 Week High
  • NKTR $37.38
  • THTX $3.20
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 67.01
  • THTX 71.86
  • Support Level
  • NKTR $21.87
  • THTX $2.28
  • Resistance Level
  • NKTR $26.89
  • THTX $3.20
  • Average True Range (ATR)
  • NKTR 2.11
  • THTX 0.04
  • MACD
  • NKTR -0.20
  • THTX 0.03
  • Stochastic Oscillator
  • NKTR 76.31
  • THTX 93.48

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Share on Social Networks: